Management of Menorrhagia

On-Demand Webinar
HCP Resources Page
Explore the multifaceted approach to managing heavy menstrual bleeding in this engaging webinar featuring medical experts Dr. Barbara Levy, Dr. Robert Rubino, Dr. Richard Stalter, and Dr. Shannon Smith. They discuss various treatment options, emphasizing patient education, communication, and the innovative CereneĀ® Cryotherapy Device. This session is invaluable for healthcare professionals seeking to deepen their understanding of menorrhagia management and the latest in minimally invasive treatments.  

Key Takeaways
  1. Emphasis on Patient Education and Communication: The experts highlight the necessity of educating patients about menorrhagia and its various treatment options. They address common misconceptions, particularly the over-reliance on hysterectomy, and advocate for informing patients about minimally invasive alternatives, including the Cerene Cryotherapy Device.
  2. Exploring Treatment Options Beyond Hormonal Therapy: The webinar covers the hesitancy surrounding hormonal treatments due to past experiences or hormone-related fears. It emphasizes the importance of discussing long-term benefits and safety of different options, including cryoablation and hysterectomy, to help patients make informed decisions.
  3. Personalized Treatment Planning: The discussion underscores the significance of understanding patients' goals and the impact of heavy menstrual bleeding on their quality of life. It advocates for a tailored approach to treatment, considering factors like fertility preservation, hormonal vs. non-hormonal treatments, and individual health conditions, such as PCOS. The Cerene Cryotherapy Device is presented as a viable option, especially for its minimal invasiveness and effectiveness in treating menorrhagia.
Complete the Form Below to View
Now Playing
Video Library
Barbara Levy, MD moderates a discussion with Geoffrey Bowers, MD and Leslie Hansen Lindner, MD on their insights on the evolution of endometrial ablation and how innovations in cryotherapy may reshape thinking around heavy menstrual bleeding treatment.
A compilation of physician perspectives on the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
Barbara Levy, MD discusses the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
James Greenberg, MD and Barbara Levy, MD discuss the implications from recent and historical publications on the rates of hysterectomy after an endometrial ablation.
James Coad, MD and Andrew Brill, MD discuss the science and benefits of cryotherapy for endometrial ablation.
Barbara Levy, MD and Todd Rumsey, MD discuss patient selection criteria for the Cerene Cryotherapy Device (27 minutes).
Barbara Levy, MD along with panelists Robert Rubino, MD, Richard Salter, MD, and Shannon Smith, MD provide insights into the management of menorrhagia. (59 minutes)
Barbara Levy, MD and Gerard Reilly, MD discuss how new innovations in cryotherapy are transforming the treatment of heavy menstrual bleeding. (45 minutes)

Important Safety Information

CereneĀ® Cryotherapy Device is indicated to ablate the endometrial lining of the uterus in premenopausal women with heavy menstrual bleeding due to benign causes for whom childbearing is complete. Pregnancy following the Cerene procedure can be dangerous; therefore, contraception must be used until menopause. The Cerene procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. As with all surgical procedures, there are risks and considerations associated with the use of the Cerene Cryotherapy Device. Temporary side effects may include cramping, nausea, vomiting, vaginal discharge and spotting. For detailed benefit and risk information, consult the Cerene Instructions for use (IFU) or your healthcare professional. Learn More